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ABSTRACT 
Background:  
Smoking is the single most preventable cause of morbidity and mortality. The evidence on 
independent associations between smoking in later life and incident frailty is scarce. 
 
Objectives:  
To examine the effect of current smoking in older people on the risk of developing frailty, 
controlling for important confounders. 
 
Methods:  
We used data of 2,542 community-dwelling older people aged >60 years in England. 
Participants were classified as current smokers or non-smokers. Frailty was defined using 
modified Fried criteria. Multivariable logistic regression models were used to examine risk of 
four-year incident frailty in current smokers compared with non-smokers, adjusted for 
demographic, socioeconomic and health variables.  
 
Results:  
Of 2,542 participants, 261 and 2,281 were current smokers and non-smokers, respectively. 
The current smokers were significantly frailer, younger, with lower BMI, less educated, less 
wealthy and lonelier compared with non-smokers at baseline. In multivariable logistic 
regression models adjusting for age and gender, current smokers were twice as likely to 
develop frailty compared with non-smokers (OR=2.07, 95%CI=1.39-3.39, p=0.001). The 
association is attenuated largely by controlling for socioeconomic status. Smoking remains 
significantly associated with incident frailty in fully adjusted models including  age, gender, 
socioeconomic status, alcohol use, education, wealth, cognitive function and loneliness 
(OR=1.60, 95%CI=1.02-2.51, p=0.04). The relationship is however attenuated when taking 
account of non-response bias through multiple imputation. 
 
Conclusions:  
Current smokers compared with non-smokers were significantly more likely to develop 
frailty over four years among community-dwelling older people. Given that smoking is a 
modifiable lifestyle factor, smoking cessation may potentially prevent or delay developing 
frailty, even in old age. 
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INTRODUCTION 
When national surveys on smoking started in the UK in 1974, 41% of women and 51% of 
men were smokers.1 The overall prevalence of smoking has been declining since then, down 
to 17% for women and 20% for men in 2014.1 Tobacco smoking is the single most 
preventable cause of morbidity and mortality in the UK.2 The National Health Service (NHS) 
spent £5.2 billion (approximately $7.5 billion) in treating smoking-related health conditions 
in 2005/06.3  
 
Smoking also increases the risk of developing a number of other diseases, such as chronic 
obstructive pulmonary disease (COPD), coronary heart disease, stroke and peripheral 
vascular disease,4 all of which can potentially have negative effects on the physical, 
psychological and social health of smokers. Disability itself limits autonomy, increases the 
risk of dependence, reduces quality of life and contributes to mortality.5 
 
Frailty is considered a precursor to, but a distinct state from, disability.6 Frailty has been 
described as a condition associated with decreased physiological reserve and increased 
vulnerability to adverse health outcomes with exposure to a stressor.7 The outcomes include 
falls,8 fractures,9 disability,10 hospitalisation11 and institutionalisation.12 Frailty has also been 
shown to be linked to worse psychological or cognitive outcomes, such as poor quality of 
life13 and dementia.14 Due to the potential for reversibility of frailty,15 identifying potentially 
modifiable risk factors of frailty may help to develop strategies to prevent or slow 
progression of adverse health outcomes associated with both frailty and smoking. As 
maintaining independence is a key priority for older people, demonstrating links with 
smoking and frailty might provide additional motivation for older smokers to quit. A previous 
systematic review showed that only a few studies have examined longitudinal associations 
between smoking and risk of incident frailty.16 Although most of these studies demonstrated 
that smokers were more likely to develop frailty, they provided effect measures that were 
unadjusted or adjusted for a limited number of confounders.16 Therefore, the independent 
association of smoking with incident frailty has not been convincingly established. We thus 
aimed to examine the association of smoking with the risk of developing frailty, controlling 
for important confounding variables and using data from a nationally representative sample 
of community-dwelling older men and women living in England. 
 
METHODS 
Study Setting and Population 
The English Longitudinal Study of Ageing (ELSA) is a multi-centre longitudinal panel study 
of a nationally representative sample of community-dwelling men and women aged 50 years 
and older in England and its detail has been published elsewhere.17 The initial participants 
(n=11,391) at wave 1 in 2002 were recruited from households that participated in the Health 
Survey for England (HSE). The panel has been followed up with every two years. Ethical 
approval for all of the ELSA waves was obtained from the National Research and Ethics 
Committee and informed consent was obtained from all participants.  
 
The current study used data of participants who were aged 60 years or older at wave 2 
(baseline), since the gait speed was not measured for those aged less than 60 years, and who 
also participated at wave 4 (follow-up). Of 6,183 men and women aged 60 years or older who 
were interviewed at wave 2, those who missed any data regarding smoking status at wave 2 
(n=3) and frailty components at waves 2 (n=1,688) were excluded. Those who were frail at 
wave 2 (n=575) were also excluded in order to examine the risk of incident frailty. Among 
3,918 participants left, 1,376 could not participate at the follow-up wave due to ill health 
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(n=44), death (n=139), refusal (n=547), being unable to contact (n=132) or other reasons 
(n=514). The final analytic sample for this study was 2,542 participants. 
 
Predictor Variable − Smoking 
Participants were classified as ‘current smoker’ or ‘non-smoker’ based on answers to the 
question ‘Do you smoke cigarettes at all nowadays?’ during the interview at wave 2. To 
examine effects of smoking cessation on frailty, the non-smokers were divided, based on data 
of when they quit smoking available from wave 3 (2 years after wave 2), into two groups: 
past smokers and never smoker. The past smokers were further divided into another two 
groups: those who quit within the last 10 years and those who quit more than 10 years ago.18 
 
Outcome Variable − Incident frailty 
Frailty was defined using the frailty phenotype criteria that Fried et al. described in the 
Cardiovascular Health Study (CHS).6 In CHS, frailty is defined using a combination of five 
physical frailty components: (1) unintentional weight loss, (2) self-reported exhaustion, (3) 
weakness, (4) slow walking speed and (5) low physical activity. Frailty is classified as having 
three or more of the five criteria. An individual who meets one or two criteria is classified as 
prefrail, and an individual with no criterion is classified as robust. Please see Appendix 1 for 
detail of definitions of the CHS criteria components, covariates and statistical analysis. 
 
RESULTS 
Table 1 and Appendix 2 present the baseline characteristics of the final analytic sample of 
2,542 participants according to smoking status as well as 1,376 who were excluded at follow-
up according to reasons for lost follow-up. Among the analytic sample at baseline, 2,281 
participants were non-smokers (1,168 never smokers and 1,113past smokers) and 261 were 
current smokers. Current smokers were significantly frailer, younger, with lower BMI, less 
educated, less wealthy and lonelier compared with non-smokers. There were no significant 
differences in gender, alcohol use and cognitive function between these two groups.  
 
In the univariate logistic regression models, various factors were significantly associated with 
a higher risk of incident frailty over four years. Current smoking was associated with an 
approximately 50% increased risk of developing frailty (OR=1.56, 95% confidence interval 
(CI)=1.06-2.29, p=0.02). Other factors associated with an increased risk of incident frailty 
were belonging to the older age group, being a female, having a higher BMI, consuming 
alcohol less frequently, having completed a lower level of education, having a lower level of 
wealth, having a lower cognitive function and having more loneliness. (Table 2) 
 
Table 3 shows the results of the multivariable logistic regression models. In Model 1 
adjusting for age and gender, current smokers were twice as likely to develop frailty at the 
time of follow-up compared with non-smokers (OR=2.07, 95%CI=1.34-3.19, p=0.001). 
Further adjusting for alcohol use did not change the odds ratio drastically (OR=2.17, 
95%CI=1.39-3.39, p=0.001). Although adding education and wealth for adjustment in Model 
3 decreased the odds ratio, current smoking remained a significant predictor of incident 
frailty (OR=1.62, 95%CI=1.05-2.52, p=0.03). In Model 4, cognitive function and loneliness 
were further adjusted for, which made little change in the association (OR=1.60, 
95%CI=1.02-2.51, p=0.04). We repeated the final model (Model 4) with multiple imputation 
by chained equations, and this attenuated the association (OR=1.48, 95%CI=0.97-2.28, 
p=0.07). 
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When COPD was added to the Model 4, current smoking was no longer a significant 
predictor of incident frailty and the OR decreased by 14.4% (OR=1.37, p=0.19). In this 
model, COPD was strongly associated with incident frailty (OR=2.58, 95%CI=1.59-4.20, 
p<0.001). These findings suggest that current smokers are more likely to develop frailty due 
to COPD, rather than smoking itself. Adding CVD or cancers to Model 4 made little changes 
in the results, which suggest that CVD and cancers are not a modulator in the associations 
between current smoking and development of frailty.  
 
In supplementary analyses, incident frailty risk for current and past smokers compared with 
never smokers was calculated. Compared with never smokers, current smokers were 
significantly more likely to develop frailty in Models 1 and 2, which became non-significant 
in Models 3 and 4. There was no significant association between past smoking and incident 
frailty in any models. (Appendix 3) Among 1,113 past smokers, 157 quit smoking within the 
last 10 years and 956 quit smoking for more than 10 years ago. Incident frailty risks of these 
two groups were not significantly different to that of non-smokers in all models. (Appendix 
4) 
 
DISCUSSION 
This prospective panel study of 2,542 British community-dwelling men and women aged 60 
years or older who were free of frailty at baseline showed that current older smokers were 
60% more likely to develop frailty than non-smokers over four years, controlling for a wide 
range of potential confounders including age, gender, alcohol use, education, wealth, 
cognitive function and loneliness. 
 
Our findings are consistent with the limited previous longitudinal research, which has shown 
in the majority of studies that smoking worsened subsequent frailty status,19-23 except for one 
study.15 
 
Mechanisms by which current smokers are more likely to develop frailty are unknown, but 
may be multifactorial given that tobacco smoke is a mixture of numerous kinds of toxic 
chemicals and compounds and can affect every organ in the body. Smoking has been shown 
to be associated with various physical and mental illnesses,4 any of which can contribute to 
the development of frailty. These health risks can be reduced substantially by smoking 
cessation, according mostly to findings from studies among middle aged adults.24 Although 
scarce, the evidence supports that one is never too old to quit smoking and older smokers can 
still benefit from quitting.25 One study showed that the risks of myocardial infarction and 
stroke were reduced by 40% within five years of smoking cessation in German older people 
aged 50 and over.26 Smoking cessation can potentially be an effective strategy to prevent or 
delay developing frailty among older smokers. This possible benefit of smoking cessation is 
supported by our findings that past smokers did not have higher risk of incident frailty than 
never smokers. Evidence suggests that older people may be less motivated by preventing 
disease such as heart attacks than younger people.27 However it is their priority to remain 
independent, able to look after themselves and engaged socially.28 Therefore knowledge that 
continued smoking in later life may increase the risk of frailty, which itself is strongly 
associated with increased dependency and increased risk of moving into care home settings, 
may provide additional motivation to encourage older smokers to quit. 
  
In the multivariable logistic regression models, the odds ratio of developing frailty in current 
smokers compared with non-smokers decreased from 2.17 to 1.62 (-25.3%) when further 
adjusted for education and wealth, which suggests that the association between smoking and 
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incident frailty can partially be explained by socioeconomic status. Lower socioeconomic 
status has been shown to be associated with a higher prevalence of smoking3 and a higher 
level and faster progression of frailty.29 Socioeconomically disadvantaged smokers typically 
are found to have developed their smoking habit earlier in their lives, and are likely to be 
more nicotine dependent, to have less social support for smoking cessation and to be less 
likely to succeed in smoking cessation attempts.30 In order to reduce the smoking-related 
health inequalities, smoking cessation measures should be effective on these hard-core 
smokers with low socioeconomic status.30 In our supplementary analysis using multiple 
imputation of covariates the relationship of smoking with frailty was attenuated further and 
becomes non-significant. 
 
COPD, CVD and cancers were separately added to the final multivariable logistic regression 
model to see if these smoking-related diseases fully explained the association between current 
smoking and incident frailty, or if there appeared to be a further independent effect of 
smoking on frailty. Only COPD changed the results significantly and current smoking no 
longer predicted incident frailty in that model, which suggests that the association appears to 
be explained by COPD. Finally our supplementary analysis suggests that the harmful effects 
of smoking on frailty are largely restricted to those who were currently smoking at baseline, 
as with even those who had more recently quit (within the last 10 years), showed no 
increased risk of frailty compared to never-smokers. 
 
There are some limitations and strengths of this study. First, due to the limited availability of 
data at the baseline wave, only current smokers and non-smokers were defined. We had to 
retrieve data from a later wave to create past and never smoker groups. We had no 
information on the extent of smoking exposure (quantity of cigarettes consumed or length of 
exposure) and we were therefore unable to explore a ‘dose-response’ relationship. It should 
be noted that the information on smoking status was self-reported and potentially subject to 
response bias. Second, our sample was restricted to those who had completed measurements 
of frailty status (e.g. gait speed, handgrip strength) in nurse interviews at two time points in 
ELSA. Those who were excluded due to missing data at follow-up were significantly frailer 
and more likely to be current smokers compared with those who were included, which 
suggests that those excluded were missing data that were not random. Therefore, this 
exclusion is likely to attenuate an association between smoking status and incident frailty. 
Whilst we attempted to account for attrition bias by using non-response weights, this 
differential loss to follow-up may have underestimated the associations between frailty and 
smoking. Third, the ELSA cohort only includes the English population and may not be 
generalisable to other populations. Fourth, as in other studies, components of CHS criteria 
were slightly modified according to availability of ELSA data, which may have affected the 
findings.31 Fifth, we used to only two time points four years apart to assess incident frailty 
risk according to smoking. Given that COPD may be an important mediator in the association 
between smoking and frailty, over many years, a study with a longer follow-up period and 
multiple data collection time points would be justified. 
 
The major strengths of this analysis are a large sample size, a prospective study design and 
the use of a wide range of potential confounders for adjustment. 
 
In conclusion, current smokers compared with non-smokers were significantly more likely to 
develop frailty over four years among British community-dwelling older people. This result 
is in line with findings of a recent systematic review.16 Given that smoking is a modifiable 
7 
 
lifestyle factor, smoking cessation may potentially prevent or delay developing frailty, even 
in old age. 
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Table 1. Summary of the baseline characteristics of analytic sample (N=2,542) 
 
Variable* Entire sample  Non-smoker  Current smoker 
 N=2,542 
Total non-smoker 
n=2,281 
Never smoker 
n=1,168 (51.2%) 
Past smoker 
n=1,113 (48.8%) 
n=261 
Frailty status      
  Robust 1,430 (56.3%) 1,319 (57.8%) 698 (59.8%) 621 (55.8%) 111 (42.5%) 
  Prefrail 1,112 (43.7%) 962 (42.2%) 470 (40.2%) 492 (44.2%) 150 (57.5%) 
Age group      
  60-64 611 (24.0%) 526 (23.1%) 276 (23.6%) 250 (22.5%) 85 (32.6%) 
  65-65 825 (32.5%) 739 (32.4%) 409 (35.0%) 330 (29.6%) 86 (33.0%) 
  70-74 542 (21.3%) 498 (21.8%) 257 (22.0%) 241 (21.7%) 44 (16.9%) 
  75-79 354 (13.9%) 320 (14.0%) 140 (12.0%) 180 (16.2%) 34 (13.0%) 
  80+ 210 (8.3%) 198 (8.7%) 86 (7.4%) 112 (10.1%) 12 (46%) 
Gender      
  Male 1,150 (45.2%) 1,032 (45.2%) 421 (36.0%) 611 (54.9%) 118 (45.2%) 
  Female 1,392 (54.8%) 1,249 (54.8%) 747 (64.0%) 502 (45.1%) 143 (54.8%) 
BMI 27.6 + 4.4 27.7 + 4.4 27.5 + 4.5 28.0 + 4.4 26.8 + 4.3 
  <=25 706 (27.8%) 613 (26.9%) 353 (30.2%) 260 (23.4%) 93 (35.6%) 
  25<, <=30 1180 (46.4%) 1071 (47.0%) 541 (46.3%) 530 (47.6%) 109 (41.8%) 
  >30 656 (25.8%) 597 (26.2%) 274 (23.5%) 323 (29.0%) 59 (22.6%) 
Alcohol      
  None 223 (9.4%) 192 (9.0%) 123 (11.1%) 69 (6.7%) 31 (13.0%) 
  1/year - 2/month 690 (29.0%) 617 (28.8%) 363 (32.6%) 254 (24.7%) 73 (30.5%) 
  1/month - 4/week 877 (36.8%) 794 (37.1%) 409 (36.7%) 385 (37.4%) 83 (36.8%) 
  5/week or more 592 (24.9%) 541 (25.2%) 218 (19.6%) 322 (31.3%) 52 (21.8%) 
Education       
  Higher education 322 (12.7%) 306 (13.4%) 164 (14.0%) 142 (12.8%) 16 (6.1%) 
  Intermediate 1,314 (51.7%) 1,201 (52.7%) 610 (52.2%) 591 (53.1%) 113 (43.3%) 
  No qualification 906 (35.6%) 774 (33.9%) 394 (33.7%) 380 (34.1%) 132 (50.6%) 
Wealth quintile      
  Richest 661 (26.3%) 619 (27.5%) 327 (28.3%) 292 (26.6%) 42 (16.3%) 
  2nd 569 (22.7%) 528 (23.4%) 258 (22.3%) 270 (24.6%) 41 (16.0%) 
  3rd 523 (20.8%) 474 (21.0%) 261 (22.6%) 213 (19.4%) 49 (19.1%) 
  4th 446 (17.7%) 393 (17.4%) 187 (16.2%) 206 (18.7%) 53 (20.6%) 
  Poorest 312 (12.4%) 240 (10.7%) 122 (10.6%) 118 (10.7%) 72 (28.0%) 
Cognitive function score 48.9 + 10.4 49.2 + 10.3 49.5 + 10.2 48.8 + 10.4 46.9 + 10.8 
Loneliness score 3.9 + 1.4 3.9 + 1.3 3.9 + 1.3 3.9 + 1.3 4.3 + 1.6 
COPD 153 (6.0%) 113 (5.0%) 53 (4.5%) 60 (5.4%) 40 (15.3%) 
* Mean + standard deviation or n (%), COPD: chronic obstructive pulmonary disease
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Table 2. Risk factors of incident frailty by univariate logistic regression models (N=2,542). 
* ref: reference group 
 
 
  
Variable Odds ratio (95%CI) p value 
Smoking Status   
  Never/past ref*  
  Current 1.56 (1.06-2.29) 0.02 
Age group   
  60-64 ref*  
  65-69 1.07 (0.63-1.83) 0.80 
  70-74 2.70 (1.64-4.44) <0.001 
  75-79 5.16 (3.13-8.51) <0.001 
  80+ 11.88 (7.09-19.92) <0.001 
Gender   
  Male ref*  
  Female 1.69 (1.28-2.23) <0.001 
BMI 1.08 (1.04-1.11) <0.001 
  <=25 ref  
  25<, <=30 0.90 (0.63-1.27) 0.53 
  >30 1.64 (1.16-2.34) <0.01 
Alcohol   
  None ref*  
  1/year - 2/month 0.57 (0.37-0.88) 0.01 
  1/month - 4/week 0.46 (0.30-0.70) <0.001 
  5/week or more 0.31 (0.19-0.51) <0.001 
Education    
  Higher education ref*  
  Intermediate 1.48 (0.88-2.51) 0.14 
  No qualification 3.73 (2.23-6.25) <0.001 
Wealth quintile   
  Richest ref*  
  2nd 1.92 (1.20-3.07) <0.01 
  3rd 1.96 (1.23-3.14) <0.01 
  4th 2.65 (1.68-4.18) <0.001 
  Poorest 5.96 (3.81-9.34) <0.001 
Cognitive function score 0.94 (0.92-0.95) <0.001 
Loneliness score 1.27 (1.17-1.38) <0.001 
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Table 3. Incident frailty risk of current smoking by multivariable logistic regression models 
(N=2,542). 
 Odds Ratio (95%CI) p value 
Model 1 2.07 (1.34-3.19) 0.001 
Model 2 2.17 (1.39-3.39) 0.001 
Model 3 1.62 (1.05-2.52) 0.03 
Model 4 1.60 (1.02-2.51) 0.04 
 
Model 1: Adjusted for age and gender 
Model 2: Further adjusted for alcohol 
Model 3: Further adjusted for education and wealth 
Model 4: Further adjusted for cognitive function and loneliness 
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Appendix 1. Methods 
Outcome Variable − Incident frailty 
In the current study, the five phenotype components are slightly modified according to data 
availability. At baseline, weight loss was defined as loss of 5% or more of body weight since 
HSE in 1998, 1999 or 2001, or body mass index (BMI) of less than 18.5 kg/m2. At follow-up, 
weight loss was defined as loss of 5% or more of body weight since baseline or BMI of less 
than 18.5 kg/m2. Exhaustion was defined based on responses to two questions from the eight-
item Center for Epidemiologic Studies Depression Scale (CES-D) on whether much of the 
time during the past week (1) they felt that everything they did was an effort and (2) they 
could not get going. Exhaustion was considered to be present if the participant answered YES 
to either or both of these questions. Handgrip strength was measured three times on each 
hand using a dynamometer and the highest measurement was used for this criterion. 
Weakness was defined as having the handgrip measurement in the lowest 20%, stratified by 
gender and BMI quartiles. Gait speed was calculated according to the average time taken to 
walk eight feet at a usual pace following two attempts. Slow walking speed was defined as 
having gait speed in the lowest 20%, stratified by gender and median height. Those who were 
in wheelchair, were bed-bound or were unable to walk without assistance were considered to 
have slow walking speed. Physical activity was ranked based on a combination of intensity 
(vigorous; moderate; mild exercise) and frequency (more than once a week; once a week; one 
to three times a month; hardly ever or never) of usual exercise involved. Low physical 
activity was defined as being in the lower two ranks out of the possible four. 
 
Covariates 
Baseline covariates that could potentially have a confounding effect on the associations 
between smoking and frailty available in ELSA, include age, gender, BMI, alcohol 
consumption, education, wealth, cognitive function, and loneliness. ELSA participants were 
asked if they were ever told by a doctor that they had or had had COPD, cardiovascular 
diseases (CVD) (angina, myocardial infarction, congestive heart failure or stroke) and 
cancers. 
 
Participants were classified into five age groups based on their age at baseline:(1) 60-64 years 
old, (2) 65-69 years old, (3) 70-74 years old (4) 75-79 years old and (5) 80 years or older. 
BMI was calculated as weight in kilograms divided by the square of height in metres. 
Alcohol use was categorised into four groups based on frequency of alcohol consumption: (1) 
not at all, (2) once a year to twice a month, (3) once a week to four days a week and (4) five 
days a week or more. Education was classified into three groups: (1) higher education, (2) 
intermediate and (3) no qualification.  The quintiles of the net total wealth, which was 
calculated as the sum of savings, investments, physical wealth and housing wealth deducting 
financial debt and mortgage debt, were used. Cognitive function was assessed using a 
composite score, summing up scores of four tests covering three domains of cognitive 
function: (1) executive function (animal naming task, distribution range: 0-57), (2) processing 
speed (letter cancellation task, distribution range: 0-64) and (3) memory (immediate and 
delayed recall tasks, distribution range: both 0-10, together 0-20), with a higher score 
suggestive of better cognitive function.17 Loneliness was assessed using a three-item short 
form of the Revised UCLA Loneliness Scale, with the score ranging from three to nine.  
 
Statistical Analyses 
Baseline characteristics were compared according to smoking status (current smoker or non-
smoker) using a t-test for continuous variables and a chi square test for categorical variables. 
Univariate logistic regression models were used to examine the risk of incident frailty for 
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baseline characteristics. Multivariable logistic regression models were used to examine the 
risk of incident frailty for being a current smoker compared with a non-smoker, adjusted for 
age, gender and other variables that were significantly associated with a risk of incident 
frailty in the univariate analyses. The longitudinal weighting was used for all analyses to 
reduce any bias caused by non-response. The longitudinal weights are created sequentially on 
top of the previous wave's weights for the core members who have participated in all the 
previous waves, in order to minimize bias from sample loss due to attrition and be 
representative of those living in England (i.e. 2002).17 
 
We conducted several supplementary analyses. The fully adjusted model was repeated using 
multiple imputation by chained equations for missing value of the covariates used for 
adjustment. It is based on the assumption of missing at random where the probability of 
missing data does not depend on unobserved data but on observed data. We also repeated the 
main analysis in order to explore the degrees to which smoking-related diseases explained the 
association between current smoking and subsequent incident frailty. Three diseases: COPD, 
CVD and cancers, were chosen because smoking is known to increase the risk of these 
diseases and they can increase the risk of frailty. These diseases were separately added to the 
final model and changes in the odds ratios before and after the addition were compared. We 
conducted a further supplementary analysis to explore if the relationships change when non-
smokers were reclassified as either ‘never smokers’ or ‘past smokers’ using data of when 
they quit smoking from another wave two years later (these data were not available for our 
main cohort at baseline). The past smokers were further divided into two groups: those who 
quit within 10 years and those who quit more than 10 years ago. The multivariable logistic 
regression models were repeated using these three and four smoking groups. 
 
All statistical analyses were conducted using StataSE 14 (StataCorp LP, College Station, 
Texas, USA) based on 2-tailed significance. The level of significance was set at p<0.05. 
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Appendix 2. The full version of baseline characteristics of analytic sample (N=2,542) and those who lost follow-up (N=1,376) 
Variable* Entire cohort Analytic sample  Non-smoker  Current smoker  Lost f/u   
 N=3,918 N=2,542 
Total non-smoker 
n=2,281 
Never smoker 
n=1,168 (51.2%) 
Past smoker 
n=1,113 (48.8%) 
n=261 
Total lost f/u 
N=1,376 
Died 
n=139 (10.1%) 
Ill health 
n=44 (3.2%) 
Other reasons 
n=1,193 (86.7%) 
Frailty status           
  Robust 2054 (52.4%) 1,430 (56.3%) 1,319 (57.8%) 698 (59.8%) 621 (55.8%) 111 (42.5%) 624 (45.4%) 40 (28.8%) 17 (38.6%) 567 (47.5%) 
  Prefrail 1864 (47.6%) 1,112 (43.7%) 962 (42.2%) 470 (40.2%) 492 (44.2%) 150 (57.5%) 752 (54.7%) 99 (71.2%) 27 (61.4%) 626 (52.5%) 
Age group           
  60-64 875 (22.3%) 611 (24.0%) 526 (23.1%) 276 (23.6%) 250 (22.5%) 85 (32.6%) 264 (19.2%) 15 (10.8%) 2 (4.5%) 247 (20.7%) 
  65-65 1202 (30.7%) 825 (32.5%) 739 (32.4%) 409 (35.0%) 330 (29.6%) 86 (33.0%) 377 (27.4%) 19 (13.7) 11 (25.0%) 347 (29.1%) 
  70-74 826 (21.1%) 542 (21.3%) 498 (21.8%) 257 (22.0%) 241 (21.7%) 44 (16.9%) 284 (20.6%) 37 (26.6%) 14 (31.8%) 233 (19.5%) 
  75-79 583 (14.9%) 354 (13.9%) 320 (14.0%) 140 (12.0%) 180 (16.2%) 34 (13.0%) 229 (16.6%) 30 (21.6%) 10 (22.7%) 189 (15.8%) 
  80+ 432 (11.0%) 210 (8.3%) 198 (8.7%) 86 (7.4%) 112 (10.1%) 12 (46%) 222 (16.1%) 38 (27.3%) 7 (15.9%) 177 (14.8%) 
Gender           
  Male 1790 (45.7%) 1,150 (45.2%) 1,032 (45.2%) 421 (36.0%) 611 (54.9%) 118 (45.2%) 640 (46.5%) 75 (54.0%) 15 (34.1%) 550 (46.1%) 
  Female 2128 (54.3%) 1,392 (54.8%) 1,249 (54.8%) 747 (64.0%) 502 (45.1%) 143 (54.8%) 736 (53.5%) 64 (46.0%) 29 (65.9%) 643 (53.9%) 
BMI 27.7 + 4.5 27.6 + 4.4 27.7 + 4.4 27.5 + 4.5 28.0 + 4.4 26.8 + 4.3 27.8 + 4.5 26.9 + 4.4 27.8 + 5.3 27.9 + 4.5 
  <=25 1099 (28.0%) 706 (27.8%) 613 (26.9%) 353 (30.2%) 260 (23.4%) 93 (35.6%) 393 (28.6%) 51 (36.7%) 16 (36.4%) 326 (27.3%) 
  25<, <=30 1761 (45.0%) 1180 (46.4%) 1071 (47.0%) 541 (46.3%) 530 (47.6%) 109 (41.8%) 581 (42.2%) 56 (40.3%) 13 (29.6%) 512 (42.9%) 
  >30 1058 (27.0%) 656 (25.8%) 597 (26.2%) 274 (23.5%) 323 (29.0%) 59 (22.6%) 402 (29.2%) 32 (23.0%) 15 (34.1%) 355 (29.8%) 
Alcohol           
  None 363 (9.3%) 223 (9.4%) 192 (9.0%) 123 (11.1%) 69 (6.7%) 31 (13.0%) 140 (10.2%) 22 (19.5%) 9 (23.7%) 109 (10.2%) 
  1/year - 2/month 1034 (26.4%) 690 (29.0%) 617 (28.8%) 363 (32.6%) 254 (24.7%) 73 (30.5%) 344 (25.0%) 27 (23.9%) 5 (13.2 %) 312 (29.2%) 
  1/month - 4/week 1322 (33.7%) 877 (36.8%) 794 (37.1%) 409 (36.7%) 385 (37.4%) 83 (36.8%) 445 (32.3%) 34 (30.1%) 14 (36.8%) 397 (37.1%) 
  5/week or more 884 (22.6%) 592 (24.9%) 541 (25.2%) 218 (19.6%) 322 (31.3%) 52 (21.8%) 292 (21.2%) 30 (26.5%) 10 (26.3%) 252 (23.6%) 
Education            
  Higher education 437 (11.2%) 322 (12.7%) 306 (13.4%) 164 (14.0%) 142 (12.8%) 16 (6.1%) 637 (46.3%) 70 (50.4%) 21 (47.7%) 546 (45.8%) 
  Intermediate 1937 (49.4%) 1,314 (51.7%) 1,201 (52.7%) 610 (52.2%) 591 (53.1%) 113 (43.3%) 623 (45.3%) 54 (38.8%) 18 (40.9%) 551 (46.2%) 
  No qualification 1543 (39.4%) 906 (35.6%) 774 (33.9%) 394 (33.7%) 380 (34.1%) 132 (50.6%) 115 (8.4%) 15 (10.8%) 5 (11.4%) 95 (8.0%) 
Wealth quintile           
  Richest 912 (23.3%) 661 (26.3%) 619 (27.5%) 327 (28.3%) 292 (26.6%) 42 (16.3%) 251 (18.2%) 26 (18.7%) 8 (19.0%) 217 (18.3%) 
  2nd 878 (22.4%) 569 (22.7%) 528 (23.4%) 258 (22.3%) 270 (24.6%) 41 (16.0%) 309 (22.5%) 26 (18.7%) 11 (26.2%) 272 (23.0%) 
  3rd 824 (21.0%) 523 (20.8%) 474 (21.0%) 261 (22.6%) 213 (19.4%) 49 (19.1%) 301 (21.9%) 31 (22.3%) 5 (11.9%) 265 (22.4%) 
  4th 706 (18.0%) 446 (17.7%) 393 (17.4%) 187 (16.2%) 206 (18.7%) 53 (20.6%) 260 (18.9%) 27 (19.4%) 6 (14.3%) 227 (19.2%) 
  Poorest 557 (14.2%) 312 (12.4%) 240 (10.7%) 122 (10.6%) 118 (10.7%) 72 (28.0%) 245 (17.8%) 29 (20.9%) 12 (28.6%) 204 (17.2%) 
Cognitive function score 47.6 + 11.0 48.9 + 10.4 49.2 + 10.3 49.5 + 10.2 48.8 + 10.4 46.9 + 10.8 45.0 + 11.8 41.8 + 12.7 44.8 + 11.5 45.4 + 11.6 
Loneliness score 4.0 + 1.4 3.9 + 1.4 3.9 + 1.3 3.9 + 1.3 3.9 + 1.3 4.3 + 1.6 4.0 + 1.5 4.2 + 1.6 3.8 + 1.4 4.0 + 1.5 
COPD 270 (6.9%) 153 (6.0%) 113 (5.0%) 53 (4.5%) 60 (5.4%) 40 (15.3%) 117 (8.5%) 20 (14.4%) 9 (20.5%) 88 (7.4%) 
* Mean + standard deviation or n (%), COPD: chronic obstructive pulmonary disease
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Appendix 3. Incident frailty risk for current and past smokers by multivariable logistic 
regression models (N=2,542).* 
 
Current smoker 
n=261 
 
Past smoker 
n=1,113 
 
 Odds Ratio (95%CI) p value Odds Ratio (95%CI) p value 
Model 1 1.93 (1.22-3.04) 0.005 0.86 (0.63-1.18) 0.35 
Model 2 2.11 (1.32-3.37) 0.002 0.94 (0.67-1.31) 0.71 
Model 3 1.56 (0.97-2.49) 0.06 0.92 (0.64-1.30) 0.62 
Model 4 1.55 (0.96-2.50) 0.08 0.94 (0.65-1.35) 0.72 
* Never smoker (n=1,168) as reference group 
Model 1: Adjusted for age and gender 
Model 2: Further adjusted for alcohol 
Model 3: Further adjusted for education and wealth 
Model 4: Further adjusted for cognitive function and loneliness 
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Appendix 4. Incident frailty risk for past smokers who quit within the last 10 years and who 
quit more than 10 years ago by multivariable logistic regression models (N=2,542).* 
 
Quit <= 10 years ago 
n=157 
 
Quit > 10 years ago 
n=956 
 
 Odds Ratio (95%CI) p value Odds Ratio (95%CI) p value 
Model 1 0.88 (0.46-1.69) 0.70 0.86 (0.62-1.19) 0.36 
Model 2 1.01 (0.51-2.00) 0.97 0.93 (0.65-1.32) 0.67 
Model 3 0.85 (0.43-1.69) 0.64 0.93 (0.64-1.33) 0.68 
Model 4 0.88 (0.43-1.79) 0.73 0.95 (0.65-1.38) 0.77 
* Never smoker (n=1,168) as reference group 
Model 1: Adjusted for age and gender 
Model 2: Further adjusted for alcohol 
Model 3: Further adjusted for education and wealth 
Model 4: Further adjusted for cognitive function and loneliness 
 
